. Studies find no COVID benefit for preventive hydroxychloroquine or for convalescent plasma - IOPAC Press "Enter" to skip to content

Spain’s Secretary of State for Health discusses health priorities with WHO
- All WHO news
WHO welcomed Mr Javier Padilla Bernáldez, Spain’s Secretary of State for Health and his delegation on 23 and 24 April...
Global immunization efforts have saved at least 154 million lives over the past 50 years
- All WHO news
A major landmark study to be published by The Lancet reveals that global immunization efforts have saved an estimated 154 million...
Leading health agencies outline updated terminology for pathogens that transmit through the air
- All WHO news
<p>Following consultation with public health agencies and experts, the World Health Organization (WHO) publishes a global technical consultation report introducing...

The right to health
- WHO Director-General speeches
Excellencies, ladies and gentlemen, Good afternoon, and thank you for having me. It’s a real honour to be with you...
Closing address at High-Level Action Day, First WHO Global Conference on Air Pollution and Health
- WHO Director-General speeches
Every human being is entitled to breathe clean air. It’s a human right. We are honoured to have the Human...
Opening address at the First WHO Global Conference on Air Pollution and Health
- WHO Director-General speeches
Excellency, second Lady Hajia Samira Bawumia of Ghana, my colleague colleague Dr Taalas, Secretary General of WMO and my sister...

Studies find no COVID benefit for preventive hydroxychloroquine or for convalescent plasma

By iopac on November 25, 2020

Mary Van Beusekom | News Writer | CIDRAP NewsNov 25, 2020″There are no compelling data to suggest that hydroxychloroquine is effective.”

Published in COVID-19

iopac